GlassScriptPhysician profile
Joyce K Aycock
NPI 1841322674
$3,700.74
in general payments reported to CMS, 2019-2025
11 companies · $256 in 2025
The $256 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,092 · 2020: $280 · 2021: $727 · 2022: $794 · 2023: $451 · 2024: $99.99 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $807.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $806.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $1,682.45 | 2019-2022 | |
| Integra Lifesciences Corporation | $542.59 | 2023-2025 | Durasorb Monofilament Mesh, Integra, Surgimend |
| W. L. Gore & Associates, INC. | $400.00 | 2019 | |
| Mentor Worldwide LLC | $363.11 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Bard Peripheral Vascular, INC. | $242.37 | 2021 | |
| Allergan, INC. | $228.76 | 2022 | |
| Galderma Laboratories, L.P. | $150.00 | 2020 | |
| Davol INC. | $33.89 | 2023 | Phasix Mesh |
| Axogen | $22.32 | 2020 | |
| Musculoskeletal Transplant Foundation INC. | $17.84 | 2021 | |
| Abbvie INC. | $17.41 | 2023 | Alloderm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joyce Aycock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.